![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Author: Reay Philip A
Publisher: Informa Healthcare
ISSN: 1472-8222
Source: Expert Opinion on Therapeutic Targets, Vol.5, Iss.4, 2001-08, pp. : 491-506
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Dendritic Cells in Tumor Immunology and Immunotherapy
Current Drug Targets, Vol. 5, Iss. 1, 2004-01 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Potent tumour immunotherapy with stem cells
Inpharma, Vol. 1, Iss. 1399, 2003-01 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Genetically Modified Dendritic Cells for Cancer Immunotherapy
Current Gene Therapy, Vol. 5, Iss. 6, 2005-12 ,pp. :